Viewing Study NCT00844428


Ignite Creation Date: 2025-12-26 @ 11:14 AM
Ignite Modification Date: 2025-12-30 @ 1:46 AM
Study NCT ID: NCT00844428
Status: COMPLETED
Last Update Posted: 2015-07-23
First Post: 2009-02-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-07
Start Date Type: None
Primary Completion Date: 2010-10
Primary Completion Date Type: ACTUAL
Completion Date: 2013-12
Completion Date Type: ACTUAL
First Submit Date: 2009-02-12
First Submit QC Date: None
Study First Post Date: 2009-02-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-12-15
Results First Submit QC Date: None
Results First Post Date: 2015-01-26
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-06-30
Last Update Post Date: 2015-07-23
Last Update Post Date Type: ESTIMATED